Virtus KAR Health Sciences Fund Class C (RCGHX)
| Fund Assets | 102.48M |
| Expense Ratio | 2.14% |
| Min. Investment | $2,500 |
| Turnover | 8.00% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 17.15 |
| YTD Return | 0.41% |
| 1-Year Return | 2.20% |
| 5-Year Return | n/a |
| 52-Week Low | 14.23 |
| 52-Week High | 17.72 |
| Beta (5Y) | n/a |
| Holdings | 24 |
| Inception Date | Feb 5, 2002 |
About RCGHX
Virtus KAR Health Sciences Fund Class C is a mutual fund focused on the healthcare sector, aiming to achieve long-term competitive returns by investing in a diversified portfolio of companies within the health sciences industry. The fund emphasizes businesses that deliver innovative and cost-effective healthcare solutions, including those involved in biotechnology, pharmaceuticals, medical devices, and related services. Its investment approach centers on high-conviction stock selection, prioritizing companies with strong market positions, consistent growth, robust financials, and effective management. The portfolio typically comprises 40 to 50 holdings, targeting themes such as biopharmaceutical advancements, preventative healthcare, and technology-enabled care delivery. The fund seeks to navigate the opportunities and challenges presented by global trends like growing healthcare spending and demographic shifts, including an aging population. Managed by Kayne Anderson Rudnick Investment Management, the fund incorporates ESG considerations and prefers firms with lower business risk, high returns on capital, and strong free cash flow. Overall, Virtus KAR Health Sciences Fund Class C plays a specialized role in the market by providing concentrated exposure to the dynamic and evolving healthcare sector.
Performance
RCGHX had a total return of 2.20% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.98%.
Top 10 Holdings
56.36% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 13.63% |
| AbbVie Inc. | ABBV | 6.32% |
| IDEXX Laboratories, Inc. | IDXX | 6.22% |
| McKesson Corporation | MCK | 4.85% |
| Intuitive Surgical, Inc. | ISRG | 4.61% |
| West Pharmaceutical Services, Inc. | WST | 4.54% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.36% |
| Mettler-Toledo International Inc. | MTD | 4.01% |
| UnitedHealth Group Incorporated | UNH | 4.00% |
| The Cooper Companies, Inc. | COO | 3.83% |